Table 2.
The adverse events with maximum severity (Grade 3/4) across all cycles of treatment
| Frequency (%) all patients (N=36) |
Frequency (%) first line patients (N=30) |
|
|---|---|---|
| Toxicity (Grade 3/4) | ||
| Hematologic | ||
| Neutropenia | 21 (58.3) | 17 (56.7) |
| Leukopenia | 20 (55.6) | 17 (56.7) |
| Thrombocytopenia | 9 (25.0) | 8 (26.7) |
| Anemia | 10 (27.8) | 9 (30.0) |
| Non-hematological | ||
| Hepatotoxicity | None | None |
| Nephrotoxicity | None | None |
| Nausea/vomiting | None | None |